PT027 compared to PT007 in patients with asthma with mannitol-induced acute airway obstruction

Trial Identifier:	D6930C00017
Sponsor:	AstraZeneca
NCTID::	NCT05555290
Start Date:	September 2022
Primary Completion Date:	November 2024
Study Completion Date:	November 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Columbia, MD, US, 21046

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.